Trial Profile

A study of prucalopride in gastroesophageal reflux disease patients affected with Ineffective esophageal motility.

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 04 Dec 2017

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Prucalopride (Primary)
Indications Gastro-oesophageal reflux; Gastrointestinal motility disorders
Focus Therapeutic Use

Most Recent Events

01 Nov 2017 Results presented at the 25th United European Gastroenterology Week
15 Sep 2017 New trial record
12 Sep 2017 Results (n=7) published in the Journal of Gastroenterology and Hepatology

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com